Document:

THIS
NOTE AND THE COMMON STOCK ISSUABLE UPON CONVERSION OF THIS NOTE HAVE NOT BEEN AND WILL NOT BE REGISTERED WITH THE UNITED STATES
SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED
UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND THE RULES AND REGULATIONS PROMULGATED THEREUNDER (THE “1933 ACT”)

 

US
$1,500,000.00

 

ENDONOVO
THERAPEUTICS, INC.

10%
SENIOR SECURED CONVERTIBLE

 REDEEMABLE NOTE DUE

NOVEMBER
30, 2019

 

FOR
VALUE RECEIVED, Endonovo Therapeutics, Inc. (the “Company”) promises to pay to the order of EAGLE EQUITIES, LLC and
its authorized successors and Permitted Assigns, defined below, (“Holder”), the aggregate principal face amount
One Million Five Hundred Thousand dollars (U.S. $1,500,000.00) on November 30, 2019 (“Maturity Date”) and to pay interest
on the principal amount outstanding hereunder at the rate of 10% per annum commencing on November 30, 2018. The interest will
be paid to the Holder in whose name this Note is registered on the records of the Company regarding registration and transfers
of this Note. The principal of, and interest on, this Note are payable at 91 Shelton Ave, Suite 107, New Haven, CT 06511, initially,
and if changed, last appearing on the records of the Company as designated in writing by the Holder hereof from time to time.
The Company will pay each interest payment and the outstanding principal due upon this Note before or on the Maturity Date, less
any amounts required by law to be deducted or withheld, to the Holder of this Note by check or wire transfer addressed to such
Holder at the last address appearing on the records of the Company. The forwarding of such check or wire transfer shall constitute
a payment of outstanding principal hereunder and shall satisfy and discharge the liability for principal on this Note to the extent
of the sum represented by such check or wire transfer. Interest shall be payable in Common Stock (as defined below) pursuant to
paragraph 4(b) herein. Permitted Assigns means any Holder assignment, transfer or sale of all or a portion of this Note with the
prior written consent of the Company and accompanied by an Opinion of Counsel as provided for in Section 2(f) of the Securities
Purchase Agreement.

 

Initials

 

    	 	 	 

    	 

    

 

This
Note is subject to the following additional provisions:

 

1.
This Note is exchangeable for an equal aggregate principal amount of Notes of different authorized denominations, as requested
by the Holder surrendering the same. No service charge will be made for such registration or transfer or exchange, except that
Holder shall pay any tax or other governmental charges payable in connection therewith. To the extent that Holder subsequently
transfers, assigns, sells or exchanges any of the multiple lesser denomination notes, Holder acknowledges that it will provide
the Company with Opinions of Counsel as provided for in Section 2(f) of the Securities Purchase Agreement.

 

2.
The Company shall be entitled to withhold from all payments any amounts required to be withheld under applicable laws.

 

3.
This Note may be transferred or exchanged only in compliance with the Securities Act of 1933, as amended (“Act”),
applicable state securities laws and Sections 2(f) and 5(f) of the Securities Purchase Agreement. Any attempted transfer to a
non-qualifying party shall be treated by the Company as void. Prior to due presentment for transfer of this Note, the Company
and any agent of the Company may treat the person in whose name this Note is duly registered on the Company’s records as
the owner hereof for all other purposes, whether or not this Note be overdue, and neither the Company nor any such agent shall
be affected or bound by notice to the contrary. Any Holder of this Note electing to exercise the right of conversion set forth
in Section 4(a) hereof, in addition to the requirements set forth in Section 4(a), and any prequalified prospective transferee
of this Note, also is required to give the Company written confirmation that this Note is being converted (“Notice of
Conversion”) in the form annexed hereto as Exhibit A. The date of receipt (including receipt by telecopy) of
such Notice of Conversion shall be the Conversion Date. All notices of conversion will be accompanied by an Opinion of Counsel.

 

4.
(a) The Holder of this Note is entitled, at its option, at any time, to convert all or any amount of the principal face amount
of this Note then outstanding into shares of the Company’s common stock (the “Common Stock”) at a price
(“Conversion Price”) for each share of Common Stock equal to 65% of the lowest closing bid price
of the Common Stock as reported on the National Quotations Bureau OTC Markets exchange which the Company’s shares
are traded or any exchange upon which the Common Stock may be traded in the future (“Exchange”), for the twenty
prior trading days including the day upon which a Notice of Conversion is received by the Company (provided such Notice
of Conversion is delivered together with an Opinion of Counsel, by fax or other electronic method of communication to the Company
after 4 P.M. Eastern Standard or Daylight Savings Time if the Holder wishes to include the same day closing price). For purposes
of the above calculations, a day shall not be considered a trading day if there was no trading volume for the Company’s
Common Stock for that particular day. If the shares have not been delivered within 3 business days, the Notice of Conversion may
be rescinded. Such conversion shall be effectuated by the Company delivering the shares of Common Stock to the Holder within 3
business days of receipt by the Company of the Notice of Conversion. Accrued, but unpaid interest shall be subject to conversion.
No fractional shares or scrip representing fractions of shares will be issued on conversion, but the number of shares issuable
shall be rounded to the nearest whole share. To the extent the Conversion Price of the Company’s Common Stock closes below
the par value per share, the Company will take all steps necessary to solicit the consent of the stockholders to reduce the par
value to the lowest value possible under law. The Company agrees to honor all conversions submitted pending this increase. In
the event the Company experiences a DTC “Chill” on its shares, the conversion price shall be decreased to 55% instead
of 65% while that “Chill” is in effect. In no event shall the Holder be allowed to effect a conversion if such
conversion, along with all other shares of Company Common Stock beneficially owned by the Holder and its affiliates would exceed
4.99% of the outstanding shares of the Common Stock of the Company (which may be increased up to 9.9% upon 60 days prior written
notice by the Investor).

 

Initials

 

    	 	2	 

    	 

    

 

(b)
Interest on any unpaid principal balance of this Note shall be paid at the rate of 10% per annum. Interest shall be paid by the
Company in Common Stock (“Interest Shares”). Holder may, at any time, send in a Notice of Conversion to the Company
for Interest Shares based on the formula provided in Section 4(a) above. The dollar amount converted into Interest Shares shall
be all or a portion of the accrued interest calculated on the unpaid principal balance of this Note to the date of such notice.

 

(c)
While this Note is outstanding, the Company may redeem this Note or any note then currently outstanding and due to the Holder,
in whole or in part by paying to the Holder an amount equal to 135% of the face amount plus any accrued interest. The Holder shall
have the right to allocate as to which note such payment shall be applied. Any partial redemption shall be in multiples of $100,000
plus accrued interest. The redemption must be closed and paid for within 3 business days of the Company sending the redemption
demand or the redemption will be invalid and the Company may not redeem this Note.

 

(d)
Upon (i) a transfer of all or substantially all of the assets of the Company to any person in a single transaction or series of
related transactions, (ii) a reclassification, capital reorganization (excluding an increase in authorized capital) or other change
or exchange of outstanding shares of the Common Stock, other than a forward or reverse stock split or stock dividend, or (iii)
any consolidation or merger of the Company with or into another person or entity in which the Company is not the surviving entity
(other than a merger which is effected solely to change the jurisdiction of incorporation of the Company and results in a reclassification,
conversion or exchange of outstanding shares of Common Stock solely into shares of Common Stock) (each of items (i), (ii) and
(iii) being referred to as a “Sale Event”), then, in each case, the Company shall, upon request of the Holder, redeem
this Note in cash for 150% of the principal amount, plus accrued but unpaid interest through the date of redemption, or at the
election of the Holder, such Holder may convert the unpaid principal amount of this Note (together with the amount of accrued
but unpaid interest) into shares of Common Stock immediately prior to such Sale Event at the Conversion Price.

 

(e)
In case of any Sale Event (not to include a sale of all or substantially all of the Company’s assets) in connection with
which this Note is not redeemed or converted, the Company shall cause effective provision to be made so that the Holder of this
Note shall have the right thereafter, by converting this Note, to purchase or convert this Note into the kind and number of shares
of stock or other securities or property (including cash) receivable upon such reclassification, capital reorganization or other
change, consolidation or merger by a holder of the number of shares of Common Stock that could have been purchased upon exercise
of the Note and at the same Conversion Price, as defined in this Note, immediately prior to such Sale Event. The foregoing provisions
shall similarly apply to successive Sale Events. If the consideration received by the holders of Common Stock is other than cash,
the value shall be as determined by the Board of Directors of the Company or successor person or entity acting in good faith.

 

Initials

 

    	 	3	 

    	 

    

 

(f)
This Note is secured pursuant to a first priority lien under a Security Interest granted to Steven Gluckstern and set forth in
a security agreement between the Company and Steven Gluckstern dated as of December 22, 2017 (the “Security Agreement”)
and the Holder shall have all of the rights set forth in the Security Agreement.

 

5.
No provision of this Note shall alter or impair the obligation of the Company, which is absolute and unconditional, to pay the
principal of, and interest on, this Note at the time, place, and rate, and in the form, herein prescribed.

 

6.
The Company hereby expressly waives demand and presentment for payment, notice of non-payment, protest, notice of protest, notice
of dishonor, notice of acceleration or intent to accelerate, and diligence in taking any action to collect amounts called for
hereunder and shall be directly and primarily liable for the payment of all sums owing and to be owing hereto.

 

7.
The Company agrees to pay all costs and expenses, including reasonable attorneys’ fees and expenses, which may be incurred
by the Holder in collecting any amount due under this Note.

 

8.
If one or more of the following described “Events of Default” shall occur:

 

(a)
The Company shall default in the payment of principal or interest on this Note or any other note issued to the Holder by the Company;
or

 

(b)
Any of the representations or warranties made by the Company herein or in any certificate or financial or other written statements
heretofore or hereafter furnished by or on behalf of the Company in connection with the execution and delivery of this Note, or
the Securities Purchase Agreement under which this note was issued shall be false or misleading in any respect; or

 

(c)
The Company shall fail to perform or observe, in any respect, any covenant, term, provision, condition, agreement or obligation
of the Company under this Note or any other note issued to the Holder; or

 

Initials

 

    	 	4	 

    	 

    

 

(d)
The Company shall (1) become insolvent (which does not include a “going concern opinion); (2) admit in writing its inability
to pay its debts generally as they mature; (3) make an assignment for the benefit of creditors or commence proceedings for its
dissolution; (4) apply for or consent to the appointment of a trustee, liquidator or receiver for its or for a substantial part
of its property or business; (5) file a petition for bankruptcy relief, consent to the filing of such petition or have filed against
it an involuntary petition for bankruptcy relief, all under federal or state laws as applicable; or

 

(e)
A trustee, liquidator or receiver shall be appointed for the Company or for a substantial part of its property or business without
its consent and shall not be discharged within sixty (60) days after such appointment; or

 

(f)
Any governmental agency or any court of competent jurisdiction at the instance of any governmental agency shall assume custody
or control of the whole or any substantial portion of the properties or assets of the Company; or

 

(g)
One or more money judgments, writs or warrants of attachment, or similar process, in excess of one hundred thousand dollars ($100,000)
in the aggregate, shall be entered or filed against the Company or any of its properties or other assets and shall remain unpaid,
un-vacated, un-bonded or un-stayed for a period of fifteen (15) days or in any event later than five (5) days prior to the date
of any proposed sale thereunder; or

 

(h)
Defaulted on or breached any term of any other note of similar debt instrument into which the Company has entered and failed to
cure such default within the appropriate grace period; or

 

(i)
The Company shall have its Common Stock delisted from an exchange (including the OTC Markets exchange) or, if the Common Stock
trades on an exchange, then trading in the Common Stock shall be suspended for more than 10 consecutive days or ceases to file
its 1934 act reports with the SEC;

 

(j)
If a majority of the members of the Board of Directors of the Company on the date hereof are no longer serving as members of the
Board;

 

(k)
The Company shall not deliver to the Holder the Common Stock pursuant to paragraph 4 herein within 3 business days of its receipt
of a Notice of Conversion which includes an Opinion of Counsel expressing an opinion which supports the issuance thereof without
a restrictive legend;

 

Initials

 

    	 	5	 

    	 

    

 

(l)
The Company shall not replenish the reserve set forth in Section 12, within 3 business days of the request of the Holder.

 

(m)
The Company shall be delinquent in its periodic report filings with the Securities and Exchange Commission; or

 

(n)
The Company shall cause to lose the “bid” price for its stock in a market (including the OTC marketplace or other
exchange); or

 

(o)
The Company shall be in default of its obligations under that certain Security Agreement, dated as of December 22, 2017, between
Steven Gluckstern and the Company and assigned to the Holder.

 

Then,
or at any time thereafter, unless cured within 5 days, and in each and every such case, unless such Event of Default shall have
been waived in writing by the Holder (which waiver shall not be deemed to be a waiver of any subsequent default) at the option
of the Holder and in the Holder’s sole discretion, the Holder may consider this Note immediately due and payable, without
presentment, demand, protest or (further) notice of any kind (other than notice of acceleration), all of which are hereby expressly
waived, anything herein or in any note or other instruments contained to the contrary notwithstanding, and the Holder may immediately,
and without expiration of any period of grace, enforce any and all of the Holder’s rights and remedies provided herein or
any other rights or remedies afforded by law. Upon an Event of Default, interest shall accrue at a default interest rate of 24%
per annum or, if such rate is usurious or not permitted by current law, then at the highest rate of interest permitted by law.
In the event of a breach of Section 8(k) the parties agree that damages shall be difficult to determine and agree on liquidated
damages in the amount of $250 per day the shares are not issued beginning on the 4th day after the conversion notice was delivered
to the Company. The agreed liquidated damages shall increase to $500 per day beginning on the 10th day. In the event of a breach
of Section 8(n), the parties agree that damages shall be difficult to determine and hereby agree to an increase of the outstanding
principal amounts by 20% as a liquidated damages payment. In case of a breach of Section 8(i), the parties agree that damages
will be difficult to determine and agree that the outstanding principal due under this Note shall increase by 50% as a liquidated
damages payment. If this Note is not paid at maturity, or within 10 days thereof, the outstanding principal due under this Note
shall increase by 10%. Further, if a breach of Section 8(m) occurs, then the Holder shall be entitled to use the lowest closing
bid price during the delinquency period as a base price for the conversion. For example, if the lowest closing bid price during
the delinquency period is $0.01 per share and the conversion discount is 50% the Holder may elect to convert future conversions
at $0.005 per share.

 

If
the Holder shall commence an action or proceeding to enforce any provisions of this Note, including, without limitation, engaging
an attorney, then if the Holder prevails in such action, the Holder shall be reimbursed by the Company for its attorneys’
fees and other costs and expenses incurred in the investigation, preparation and prosecution of such action or proceeding.

 

Initials

 

    	 	6	 

    	 

    

 

9.
In case any provision of this Note is held by a court of competent jurisdiction to be excessive in scope or otherwise invalid
or unenforceable, such provision shall be adjusted rather than voided, if possible, so that it is enforceable to the maximum extent
possible, and the validity and enforceability of the remaining provisions of this Note will not in any way be affected or impaired
thereby.

 

10.
Neither this Note nor any term hereof may be amended, waived, discharged or terminated other than by a written instrument signed
by the Company and the Holder.

 

11.
The Company represents that it is not a “shell” issuer and that if it previously has been a “shell” issuer
that at least 12 months have passed since the Company has reported Form 10 type information indicating it is no longer a “shell
issuer.

 

12.
The Company shall issue irrevocable transfer agent instructions reserving 90,000,000 shares of its Common Stock for conversions
under this Note (the “Share Reserve”). Upon full conversion of this Note, any shares remaining in the Share Reserve
shall be cancelled. The Company will reimburse the Holder for conversions paid by the Holder. The Company should at all times
reserve a minimum of four times the amount of shares required if the note would be fully converted. The Holder may reasonably
request increases from time to time to reserve such amounts. The Company will instruct its transfer agent to provide the outstanding
share information to the Holder in connection with its conversions.

 

13.
The Company will give the Holder direct notice of any corporate actions, including but not limited to name changes, stock splits,
recapitalizations etc. This notice shall be given to the Holder as soon as possible under law.

 

14.
This Note shall be governed by and construed in accordance with the laws of Nevada applicable to contracts made and wholly to
be performed within the State of Nevada and shall be binding upon the successors and assigns of each party hereto. The Holder
and the Company hereby mutually waive trial by jury and consent to exclusive jurisdiction and venue in the courts of the State
of New York or in the Federal courts sitting in the county or city of New York. This Agreement may be executed in counterparts,
and the facsimile transmission of an executed counterpart to this Agreement shall be effective as an original. IN WITNESS WHEREOF,
the Company has caused this Note to be duly executed by an officer thereunto duly authorized.

 

Dated:
as of November 30, 2018

 

	 	ENDONOVO
    THERAPEUTICS, INC.
	 	 	                         
	 	By:	 
	 	Title:	CEO

 

Initials

 

    	 	7	 

    	 

    

 

EXHIBIT
A

 

NOTICE
OF CONVERSION

 

(To
be Executed by the Registered Holder in order to Convert the Note)

 

The
undersigned hereby irrevocably elects to convert $____________of the above Note into____________Shares of Common Stock of Endonovo
Therapeutics, Inc. (“Shares”) according to the conditions set forth in such Note, as of the date written below.

 

If
Shares are to be issued in the name of a person other than the undersigned, the undersigned will pay all transfer and other taxes
and charges payable with respect thereto.

 

	Date
    of Conversion:	 

	Applicable
    Conversion Price:	 

	Signature:	 
		[Print
Name of Holder and Title of Signer]

 

	Address:
    	 
	 	 

 

	SSN
    or EIN:	 

	Shares
    are to be registered in the following name: 	 

 

	Name:	 

	Address:	 

	Tel:	 	 
	Fax:	 	 

	SSN
    or EIN:	 	 

 

	Shares
    are to be sent or delivered to the following account:	 

 

	Account
Name:	 

	 Address: 	 

 

Initials

 

    	 	8Exhibit 10.1

 

Termination
AND RELEASE AGREEMENT

 

This Termination and
Release Agreement (the “Agreement”) is entered into by and between VITAXEL GROUP LIMITED, a Nevada corporation
(the “Company” or “Vitaxel”) and GRANDE LEGACY INC. (“Grande Legacy”)
as of this 5th day of December, 2018.

 

 WHEREAS,
the Company, as purchaser, and Grande Legacy and its shareholders (each, a “Shareholder”) entered into an agreement
for the acquisition (the “Acquisition”) by the Company of all of Grande Legacy’s shares from its Shareholders,
on December 15, 2017 (as amended through the date hereof, the “Acquisition Agreement”); and

 

 WHEREAS,
among other conditions precedent to the closing of the Acquisition, the Company was required to obtain shareholder consent for
the increase of its capitalization and issuance of an aggregate of 75,000,000 shares to Grande Legacy’s shareholders; and

 

 WHEREAS,
the Company has not been able to satisfy its conditions precedent to the closing of the Acquisition and has already received
notice of termination by Grande Legacy which the parties have been negotiating in good faith; and

 

WHEREAS,
the parties hereto desire to therefore terminate the Acquisition Agreement and release one another from any and all obligations
thereto, but to continue in full force and effect any other agreements among the parties, to wit, and without limitation, the
License Agreement dated January 5, 2017 (the “License Agreement”) and any other agreements among the parties.

 

NOW,
THEREFORE, based on the mutual premises and full and valid consideration of the parties, the receipt and sufficiency of which
is hereby acknowledged, the Company and Grande Legacy hereby agree as follows:

 

1.           Termination
of All Agreements. The parties acknowledge and agree that the Acquisition Agreement, as amended and in effect from time to
time and any and all obligations or agreements relating thereto, whether written, oral or implied, are hereby terminated in full
with prejudice. The Parties hereto hereby agree that no amounts remain due under the Acquisition Agreement, that there are no penalties
relating to termination of the Acquisition Agreement and that no party is indebted to any other party or their affiliates as a
result of said agreement or this Agreement.

 

2.           Continuation
of Other Business Relationships. Notwithstanding the foregoing termination of the Acquisition Agreement, the parties hereto
agree that the License Agreement, the Management Agreement, entered into in July of 2018, as amended and in effect from time to
time, and any other agreements or relationships of the parties are unaffected hereby and shall continue in accordance with the
terms thereof.

 

3.           General
Releases.

 

(a)    Company Releases.
For good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, including without limitation
the mutual promises set forth in this Agreement, the Company, for itself, its parents, affiliates, subsidiaries, divisions, groups
and past and present officers, directors, employees, agents, representatives, attorneys, accountants, auditors, consultants, administrators,
beneficiaries, predecessors, successors and assigns (collectively, “Company Release Parties”) and any
person or entity claiming by or through any of the foregoing hereby RELEASE AND DISCHARGE Grande Legacy and its Shareholders, attorneys,
accountants, auditors, consultants, successors and assigns in any capacity whatsoever (collectively, “GL Release Parties”)
of and from all actions, causes of action, suits, debts, dues, sums of money, claims for breaches of contract, claims for breaches
of fiduciary duties or conflicts of interest, claims of entitlement to securities, claims for violations of securities laws or
regulations, compensation, damages or otherwise.

 

     

     

    

 

(b)     Grande
Legacy Releases. For good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, including
without limitation the mutual promises set forth in this agreement for and of itself and any of the GL Release Parties, hereby
RELEASES AND DISCHARGES the Company Release Parties of and from all actions, causes of action, suits, debts, dues, sums of money,
claims for breaches of contract, claims for breaches of fiduciary duties or conflicts of interest, claims of entitlement to securities,
claims for violations of securities laws or regulations, compensation, damages or otherwise.

 

(c)     No
Initiation of Claims. Subject to satisfactory compliance with Section 3, the parties agree not to institute, instigate,
urge, support or encourage, any action against any other party or their affiliates insofar as they relate to the releases herein.

 

4.           Miscellaneous.
(a) If any provision of this Agreement is held invalid for any reason, the other provisions of this Agreement will remain in full
force and effect.

 

5.           This
Agreement may be signed by one or more counterparts or by fax, each of which shall be valid and binding as against the signor
when counter executed.

 

IN WITNESS WHEREOF,
the parties have executed this Termination and Release Agreement effective as of the Effective Date set forth above.

 

	 	 	VITAXEL GROUP LIMITED 
	 	 	 
	 	 	By:	 
	 	 	Name:
	 	 	Title:

 

	GRANDE LEGACY INC. 	 
	 	 	 
	By:	 	 
	Name:	 
	Title:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00290-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00290-of-00352.parquet"}]]